Sign in

CIK 0001596967

  • Large accelerated filer

Moelis & Co

Sign in to watch
Ticker
MC
Exchange
NYSE
Industry
Investment Advice
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464500216
Phone
+1 212-883-3800
Business address
399 PARK AVENUE, 5TH FLOOR, NEW YORK, NY, 10022
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$129,902
in 1 filing

Net −$129,902. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Shropshire Kenneth −$130K Director sold 20% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-21 WATANABE OSAMU R. General Counsel, Secretary Exercise or conversion · 2022 Incentive Restricted Stock Units −1,847.9 7,394.77
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Exercise or conversion +8,465.95 8,465.95
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Shares withheld for taxes −1.95 $52.60 $103 8,464
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Sale −4,798 $52.60 $252K 3,666
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Exercise or conversion · 2018 Incentive Restricted Stock Units −1,295.29 0
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Exercise or conversion · 2019 Incentive Restricted Stock Units −2,656.09 2,656.09
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Exercise or conversion · 2020 Incentive Restricted Stock Units −1,367.11 2,736.7
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Exercise or conversion · 2021 Incentive Restricted Stock Units −1,299.57 3,898.7
2024-02-21 Pilcher Ciafone Katherine Chief Operating Officer Exercise or conversion · 2022 Incentive Restricted Stock Units −1,847.9 7,394.77
2024-02-21 MAHMOODZADEGAN NAVID Co-President, MD Sale −20,311 $54.68 $1.1M 33,906
2024-02-20 MAHMOODZADEGAN NAVID Co-President, MD Sale −25,642 $55.29 $1.4M 54,217
2024-02-16 MAHMOODZADEGAN NAVID Co-President, MD Sale −20,001 $55.82 $1.1M 79,859
2024-02-15 Cantor Eric Vice Chairman, MD Grant or award · 2023 Vested Incentive RSUs +31,109 31,109
2024-02-15 WATANABE OSAMU R. General Counsel, Secretary Grant or award · 2023 Vested Incentive RSUs +7,319 7,319
2024-02-15 Callesano Christopher Principal Accounting Officer Grant or award · 2023 Incentive RSUs +1,921 1,921
2024-02-09 SIMON JOSEPH Chief Financial Officer Sale −3,720 $54.90 $204K 7,000
2024-02-09 SIMON JOSEPH Chief Financial Officer Sale −3,500 $54.70 $191K 3,500
2024-02-09 SIMON JOSEPH Chief Financial Officer Sale −3,500 $54.50 $191K 0
2024-02-08 Callesano Christopher Principal Accounting Officer Sale −1,040 $53.59 $56K 0
2024-02-08 Cantor Eric Vice Chairman, MD Exercise or conversion +1,736.07 173,869.07

Page 32 of 35 · 685 trades